The rules of IBD-AID were first published in 2017 and until now there were no randomized, controlled trials conducted in order to confirm the initial, promising reports on the use of this diet as an adjunct therapy for the treatment of IBD [104,116]. This evidence concerns the gene AICDA and irritable bowel syndrome.